FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

Trump says he could deploy US military in American cities, claims ‘courts wouldn’t get involved’

Federal employees, public school teachers, and government officials donated to Jay Jones after text scandal

Newsom invokes Scripture in attack on GOP over shutdown affecting food assistance: ‘Cruelty is the policy’

Pentagon orders managers to fire civilian workers with ‘speed and conviction’

Nanny found with suspected psychedelic mushrooms accused of fatal stabbing, screwdriver attack on family

Trump fires entire design review panel overseeing planned ballroom and arch

Mamdani forced to address unearthed video exposing vile NYPD comparison

Illegal immigrant deported 30 years after brutal murder of Philadelphia teen Eddie Polec on church steps

Senate Republicans Defect, Ignore Vance and Vote to Block Trump Trade Strategy

Allegedly Disease-Ridden, ‘Aggressive’ Research Monkeys Escape After Truck Crash

‘President Is Losing Support’: MTG in Heated Clash Over Government Shutdown

An Unstated Objective for Dems’ Prolonged Shutdown in Relation to Midterms May Have Just Been Revealed

Transgender rabbi booted from Biden WH headlines pro-Mamdani ad ahead of Election Day

CONFIRMED: 160+ Republicans Targeted by Biden DOJ’s ‘Arctic Frost’ Witch Hunt – House Judiciary Committee Drops Bomb

Senate Republicans defy Vance’s warning, vote to block Trump’s Brazil tariffs amid shutdown

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”